1. Home
  2. NMRA vs EM Comparison

NMRA vs EM Comparison

Compare NMRA & EM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • EM
  • Stock Information
  • Founded
  • NMRA 2019
  • EM 2017
  • Country
  • NMRA United States
  • EM China
  • Employees
  • NMRA N/A
  • EM N/A
  • Industry
  • NMRA
  • EM Other Consumer Services
  • Sector
  • NMRA
  • EM Consumer Discretionary
  • Exchange
  • NMRA Nasdaq
  • EM Nasdaq
  • Market Cap
  • NMRA 268.5M
  • EM 286.5M
  • IPO Year
  • NMRA 2023
  • EM 2021
  • Fundamental
  • Price
  • NMRA $1.57
  • EM $1.36
  • Analyst Decision
  • NMRA Hold
  • EM Hold
  • Analyst Count
  • NMRA 8
  • EM 1
  • Target Price
  • NMRA $5.83
  • EM $1.25
  • AVG Volume (30 Days)
  • NMRA 376.3K
  • EM 1.5M
  • Earning Date
  • NMRA 11-11-2025
  • EM 11-26-2025
  • Dividend Yield
  • NMRA N/A
  • EM N/A
  • EPS Growth
  • NMRA N/A
  • EM N/A
  • EPS
  • NMRA N/A
  • EM N/A
  • Revenue
  • NMRA N/A
  • EM $259,541,587.00
  • Revenue This Year
  • NMRA N/A
  • EM $3.30
  • Revenue Next Year
  • NMRA N/A
  • EM $5.26
  • P/E Ratio
  • NMRA N/A
  • EM N/A
  • Revenue Growth
  • NMRA N/A
  • EM N/A
  • 52 Week Low
  • NMRA $0.61
  • EM $0.50
  • 52 Week High
  • NMRA $17.19
  • EM $1.45
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 46.94
  • EM 65.10
  • Support Level
  • NMRA $1.42
  • EM $1.32
  • Resistance Level
  • NMRA $1.59
  • EM $1.37
  • Average True Range (ATR)
  • NMRA 0.10
  • EM 0.03
  • MACD
  • NMRA -0.03
  • EM -0.00
  • Stochastic Oscillator
  • NMRA 36.14
  • EM 70.00

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

About EM Smart Share Global Limited

Smart Share Global Ltd is a consumer tech company providing mobile device charging services through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Geographically, the company generates revenue from the PRC. The company has two segments, the mobile device charging segment and the PV business segment. The company generates the majority of its revenue from the mobile device charging segment.

Share on Social Networks: